Ryan Tunis
Stock Analyst at Cantor Fitzgerald
(3.55)
# 838
Out of 5,123 analysts
44
Total ratings
63.64%
Success rate
4.17%
Average return
Main Sectors:
Stocks Rated by Ryan Tunis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WRB W. R. Berkley | Maintains: Overweight | $76 → $75 | $70.95 | +5.71% | 2 | Feb 2, 2026 | |
| TRV The Travelers Companies | Maintains: Overweight | $316 → $319 | $296.26 | +7.68% | 5 | Feb 2, 2026 | |
| MRSH Marsh & McLennan Companies | Maintains: Overweight | $208 → $212 | $192.06 | +10.38% | 1 | Feb 2, 2026 | |
| HIG The Hartford Insurance Group | Maintains: Overweight | $160 → $165 | $141.45 | +16.65% | 7 | Feb 2, 2026 | |
| AON Aon plc | Maintains: Overweight | $393 → $412 | $349.28 | +17.96% | 2 | Feb 2, 2026 | |
| WTW Willis Towers Watson | Maintains: Neutral | $365 → $345 | $341.34 | +1.07% | 1 | Jan 14, 2026 | |
| TRUP Trupanion | Maintains: Neutral | $50 → $42 | $32.65 | +28.66% | 1 | Jan 14, 2026 | |
| RYAN Ryan Specialty Holdings | Maintains: Neutral | $63 → $52 | $47.79 | +8.81% | 1 | Jan 14, 2026 | |
| RNR RenaissanceRe Holdings | Maintains: Neutral | $252 → $282 | $300.37 | -6.12% | 1 | Jan 14, 2026 | |
| LMND Lemonade | Maintains: Overweight | $85 → $92 | $72.95 | +26.11% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $470 → $422 | $415.90 | +1.47% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $111 | $65.30 | +70.00% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $348 → $344 | $318.26 | +8.09% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $309 | $327.83 | -5.74% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $344 → $282 | $250.79 | +12.44% | 3 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $77 | $76.10 | +1.18% | 5 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $93 → $97 | $101.06 | -4.02% | 1 | Jan 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $208.50 | -59.23% | 6 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $114 | $213.66 | -46.64% | 3 | Aug 7, 2018 |
W. R. Berkley
Feb 2, 2026
Maintains: Overweight
Price Target: $76 → $75
Current: $70.95
Upside: +5.71%
The Travelers Companies
Feb 2, 2026
Maintains: Overweight
Price Target: $316 → $319
Current: $296.26
Upside: +7.68%
Marsh & McLennan Companies
Feb 2, 2026
Maintains: Overweight
Price Target: $208 → $212
Current: $192.06
Upside: +10.38%
The Hartford Insurance Group
Feb 2, 2026
Maintains: Overweight
Price Target: $160 → $165
Current: $141.45
Upside: +16.65%
Aon plc
Feb 2, 2026
Maintains: Overweight
Price Target: $393 → $412
Current: $349.28
Upside: +17.96%
Willis Towers Watson
Jan 14, 2026
Maintains: Neutral
Price Target: $365 → $345
Current: $341.34
Upside: +1.07%
Trupanion
Jan 14, 2026
Maintains: Neutral
Price Target: $50 → $42
Current: $32.65
Upside: +28.66%
Ryan Specialty Holdings
Jan 14, 2026
Maintains: Neutral
Price Target: $63 → $52
Current: $47.79
Upside: +8.81%
RenaissanceRe Holdings
Jan 14, 2026
Maintains: Neutral
Price Target: $252 → $282
Current: $300.37
Upside: -6.12%
Lemonade
Jan 14, 2026
Maintains: Overweight
Price Target: $85 → $92
Current: $72.95
Upside: +26.11%
Jan 14, 2026
Maintains: Neutral
Price Target: $470 → $422
Current: $415.90
Upside: +1.47%
Jan 14, 2026
Maintains: Overweight
Price Target: $125 → $111
Current: $65.30
Upside: +70.00%
Jan 14, 2026
Maintains: Neutral
Price Target: $348 → $344
Current: $318.26
Upside: +8.09%
Jan 14, 2026
Maintains: Neutral
Price Target: $300 → $309
Current: $327.83
Upside: -5.74%
Jan 14, 2026
Downgrades: Neutral
Price Target: $344 → $282
Current: $250.79
Upside: +12.44%
Jan 14, 2026
Maintains: Neutral
Price Target: $80 → $77
Current: $76.10
Upside: +1.18%
Jan 14, 2026
Maintains: Neutral
Price Target: $93 → $97
Current: $101.06
Upside: -4.02%
Oct 18, 2019
Maintains: Outperform
Price Target: $90 → $85
Current: $208.50
Upside: -59.23%
Aug 7, 2018
Initiates: Outperform
Price Target: $114
Current: $213.66
Upside: -46.64%